These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17255734)

  • 21. Bridging the gap between antiretroviral access and adherence in Mexico.
    Campero L; Herrera C; Kendall T; Caballero M
    Qual Health Res; 2007 May; 17(5):599-611. PubMed ID: 17478643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.
    Protopopescu C; Raffi F; Roux P; Reynes J; Dellamonica P; Spire B; Leport C; Carrieri MP;
    J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly active antiretroviral therapy for injection drug users: physician-recommended strategies for enhanced adherence.
    Vassilev ZP; Hagan H
    Antivir Ther; 2004 Jun; 9(3):461. PubMed ID: 15259910
    [No Abstract]   [Full Text] [Related]  

  • 24. Improving adherence to antiretroviral therapies: challenges and strategies.
    HIV Inside; 2002; 4(2):1, 3-12. PubMed ID: 12400482
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacoepidemiological approach to the predisposing factors for highly active antiretroviral therapy failure in an HIV-positive cohort from Cordoba City (Argentina) 1995-2005.
    Soria EA; Cadile II; Allende LR; Kremer LE
    Int J STD AIDS; 2008 May; 19(5):335-8. PubMed ID: 18482965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence to antiretroviral therapy in pregnancy.
    Kingston MA; Letham CJ; McQuillan O
    Int J STD AIDS; 2007 Nov; 18(11):787-9. PubMed ID: 18005515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of depression in predicting antiretroviral adherence in Ugandan parents and their children initiating HAART in the MTCT-plus family treatment model: commentary on Jayne Byakika-Tusiime et al. 2009.
    Nakimuli-Mpungu E; Musisi S
    AIDS Behav; 2009 Oct; 13(5):969-72. PubMed ID: 19662522
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment of changes in adherence and quality of life after the simplification of antiretroviral treatment.
    Fumaz CR; Clotet B
    IAPAC Mon; 2003 Jul; 9(7):145, 165. PubMed ID: 12951956
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of anger in adherence to highly active antiretroviral treatment in patients infected with HIV.
    Leombruni P; Fassino S; Lavagnino L; Orofino G; Morosini P; Picardi A
    Psychother Psychosom; 2009; 78(4):254-7. PubMed ID: 19468260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly active antiretroviral therapy (HAART)--plus: next steps to enhance HAART in resource-limited areas?
    Flanigan TP; Wools-Kaloustain K; Harwell J; Cu-Uvin S; Kimaiyo S; Carter EJ
    Clin Infect Dis; 2007 Dec; 45(11):1499-501. PubMed ID: 17990234
    [No Abstract]   [Full Text] [Related]  

  • 31. Comment: Factors affecting patient adherence to highly active antiretroviral therapy.
    Ngo C; Sansgiry SS
    Ann Pharmacother; 2004 Mar; 38(3):511; author reply 511. PubMed ID: 14755061
    [No Abstract]   [Full Text] [Related]  

  • 32. Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
    Elliott JH; Lynen L; Calmy A; De Luca A; Shafer RW; Zolfo M; Clotet B; Huffam S; Boucher CA; Cooper DA; Schapiro JM
    AIDS; 2008 Oct; 22(16):2053-67. PubMed ID: 18753937
    [No Abstract]   [Full Text] [Related]  

  • 33. Optimal drug treatment regimens for HIV depend on adherence.
    Krakovska O; Wahl LM
    J Theor Biol; 2007 Jun; 246(3):499-509. PubMed ID: 17320115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to the antiretroviral treatment in asymptomatic HIV-infected patients.
    López-Suárez A; Fernández-Gutiérrez del Alam ; Pérez-Guzmán E; Girón-González JA
    AIDS; 1998 Apr; 12(6):685-6. PubMed ID: 9583618
    [No Abstract]   [Full Text] [Related]  

  • 35. Time, self and the medication day: a closer look at the everyday work of 'adherence'.
    McCoy L
    Sociol Health Illn; 2009 Jan; 31(1):128-46. PubMed ID: 19170973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence to antiretroviral therapy in resource-limited settings: everything matters.
    Hawkins C; Murphy R
    AIDS; 2007 May; 21(8):1041-2. PubMed ID: 17457099
    [No Abstract]   [Full Text] [Related]  

  • 37. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
    Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral therapy adherence in children: outcomes from Africa.
    Reddi A; Leeper SC
    AIDS; 2008 Apr; 22(7):906-7. PubMed ID: 18427213
    [No Abstract]   [Full Text] [Related]  

  • 39. Initial antiretroviral drugs.
    Rojo P; Gonzalez-Tome MI; Ramos JT
    Pediatr Infect Dis J; 2007 Dec; 26(12):1167; author reply 1167. PubMed ID: 18043466
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of patient adherence to antiretroviral therapy on the progression of cervical dysplasia among HIV-infected women.
    Bernal A; Walters ST; Paulson RM; Mubasher M
    AIDS Read; 2008 Jul; 18(7):382-5. PubMed ID: 18655315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.